Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Moving toward combination lipi...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease

Bibliographic Details
Main Authors: Kamil F. Faridi, Nihar R. Desai
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:American Journal of Preventive Cardiology
Subjects:
Atherosclerotic cardiovascular disease
Secondary prevention
LDL cholesterol
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667723000326
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2666667723000326

Similar Items

  • Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
    by: Albosta MS, et al.
    Published: (2023-07-01)
  • Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease
    by: Danh Q. Nguyen, et al.
    Published: (2024-06-01)
  • The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
    by: Omar Mhaimeed, et al.
    Published: (2024-06-01)
  • Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
    by: Teimur Kayani, et al.
    Published: (2024-03-01)
  • Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
    by: Saket Girotra, et al.
    Published: (2023-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs